Workflow
Runben Biotechnology (603193)
icon
Search documents
个护用品板块11月6日跌0.3%,润本股份领跌,主力资金净流出2385.36万元
证券之星消息,11月6日个护用品板块较上一交易日下跌0.3%,润本股份领跌。当日上证指数报收于 4007.76,上涨0.97%。深证成指报收于13452.42,上涨1.73%。个护用品板块个股涨跌见下表: | 代码 | 名称 | | 主力净流入(元) | 主力净占比 游资净流入 (元) | | 游资净占比 散户净流入 (元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 600249 | 两面针 | | 1118.45万 | 8.29% | 291.52万 | 2.16% | -1409.97万 | -10.45% | | 003006 | 自亚股份 | 543.42万 | | 8.57% | -137.82万 | -2.17% | -405.60万 | -6.40% | | 6030509 | 倍加洁 | 238.87万 | | 3.63% | -16.12万 | -0.25% | -222.74万 | -3.39% | | 001328 | 登康口腔 | 182.14万 | | 4.85% | 97.56万 | ...
润本生物技术股份有限公司2025年第三次临时股东会决议公告
证券代码:603193 证券简称:润本股份 公告编号:2025-047 润本生物技术股份有限公司 2025年第三次临时股东会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示: (二)股东会召开的地点:广东省广州市天河区珠江新城华夏路28号富力盈信大厦40楼润本生物技术股份 有限公司会议室 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况: ■ (四)表决方式是否符合《公司法》及《公司章程》的规定,股东会主持情况等。 本次股东会由公司董事会召集,公司董事长赵贵钦先生主持。本次股东会采用现场投票和网络投票相结 合的方式召开并表决,会议的召开及表决符合《公司法》及《公司章程》的规定。 (五)公司董事和董事会秘书的出席情况 1、公司在任董事6人,出席6人; ● 本次会议是否有否决议案:无 一、会议召开和出席情况 (一)股东会召开的时间:2025年11月5日 ■ 2、董事会秘书出席了本次会议。 (二)涉及重大事项,5%以下股东的表决情况 ■ 二、议案审议情况 (一)非累积投票议案 1、议案名称:《 ...
润本股份(603193) - 关于润本生物技术股份有限公司2025年第三次临时股东会的法律意见书
2025-11-05 10:01
广东广信君达律师事务所 关于润本生物技术股份有限公司 2025 年第三次临时股东会的法律意见书 致:润本生物技术股份有限公司 广东广信君达律师事务所(以下简称"本所")接受润本生物技术股份有限公司(以下简 称"公司")的委托,指派张伟、马小希律师(以下简称"本律师")出席了公司于 2025 年 11 月 5 日(星期三)下午 15:30 在广东省广州市天河区华夏路 28 号富力盈信大厦 40 楼公司 会议室召开的 2025 年第三次临时股东会(以下简称"本次股东会"),并依据《中华人民共 和国公司法》、《中华人民共和国证券法》、《上市公司股东会规则》、《上海证券交易所股 票上市规则》等中国现行法律、法规和其它规范性法律文件(以下合称"法律法规")以及《润 本生物技术股份有限公司章程》(以下简称"公司章程")的有关规定,就本次股东会的召集 和召开程序、出席会议人员的资格和召集人资格、表决程序和表决结果等相关事宜出具法律意 见。 为出具本法律意见书,本律师听取了公司就有关事实的陈述和说明,审查了公司提供的相 关文件,包括但不限于: 1. 公司章程; 2. 第二届董事会第十次会议决议公告; 3. 公司于 2025 ...
润本股份(603193) - 2025年第三次临时股东会决议公告
2025-11-05 10:00
证券代码:603193 证券简称:润本股份 公告编号:2025-047 润本生物技术股份有限公司 2025年第三次临时股东会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 本次会议是否有否决议案:无 一、 会议召开和出席情况 (一)股东会召开的时间:2025 年 11 月 5 日 (四)表决方式是否符合《公司法》及《公司章程》的规定,股东会主持情况等。 本次股东会由公司董事会召集,公司董事长赵贵钦先生主持。本次股东会采 用现场投票和网络投票相结合的方式召开并表决,会议的召开及表决符合《公司 二、 议案审议情况 (一)非累积投票议案 1、 议案名称:《关于续聘会计师事务所的议案》 审议结果:通过 表决情况: (二)股东会召开的地点:广东省广州市天河区珠江新城华夏路 28 号富力盈信大 厦 40 楼润本生物技术股份有限公司会议室 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况: | 1、出席会议的股东和代理人人数 | 342 | | --- | --- | | 2、出席会议的股东所持有 ...
格局生变,优选成长
Group 1: Industry Overview - The cosmetics retail sales in China grew by 3.9% year-on-year from January to September 2025, slightly underperforming the overall retail market by 0.6 percentage points, indicating a stable demand environment [4][14]. - Online platforms like Tmall and Douyin are experiencing a shift, with Tmall showing signs of recovery due to flash sales and member subsidies, while Douyin's growth has slightly slowed down [17][20]. - The demand for high-end and cost-effective products is increasing, while the mid-range segment is facing pressure due to a more conservative consumer environment [5][41]. Group 2: Competitive Landscape - The trend of domestic brands replacing foreign ones is slowing down, with leading foreign brands like L'Oréal and Estée Lauder showing signs of recovery in the Chinese market [23][24]. - The growth of domestic brands is becoming more differentiated, with some brands like Proya and Shiseido experiencing declines, while others like Youngor and Shanghai Jahwa continue to grow [23][24]. - The industry is witnessing an acceleration in the multi-brand matrix among leading companies, which is expected to increase market concentration [27][28]. Group 3: Key Companies - The report highlights several companies with strong growth potential, including Ruya Chen, Shumei Co., and Maogeping, which are expected to benefit from their brand strength and market positioning [3][54]. - Companies like Dekang Oral Care and Shanghai Jahwa are noted for their stable fundamentals and potential for marginal improvement, while others like Jinbo Biological and Huaxi Biological are anticipated to reach turning points [54]. - Ruya Chen's self-owned brand, Zhenjia, has shown significant growth, with a revenue increase of 345% year-on-year in Q3 2025, indicating strong brand development capabilities [60].
个护用品板块11月4日跌0.95%,登康口腔领跌,主力资金净流出4158.26万元
证券之星消息,11月4日个护用品板块较上一交易日下跌0.95%,登康口腔领跌。当日上证指数报收于 3960.19,下跌0.41%。深证成指报收于13175.22,下跌1.71%。个护用品板块个股涨跌见下表: | 代码 | 名称 | 主力净流入(元) | 主力净占比 游资净流入 (元) | | 游资净占比 散户净流入 (元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 300658 延江股份 | | > 998.97万 | 10.29% | -63.52万 | -0.65% | -935.45万 | -9.64% | | 600249 | 两面针 | 634.37万 | 3.02% | -1228.32万 | -5.86% | 593.95万 | 2.83% | | 605009 豪悦护理 | | 551.80万 | 12.92% | 151.90万 | 3.56% | -703.70万 | -16.48% | | 301108 洁雅股份 | | -17.30万 | -0.24% | 146.78万 | 2.06% | -129 ...
个护用品板块11月3日跌0.38%,依依股份领跌,主力资金净流出4720.65万元
Market Overview - The personal care products sector experienced a decline of 0.38% on November 3, with Yiyi Co., Ltd. leading the drop [1] - The Shanghai Composite Index closed at 3976.52, up 0.55%, while the Shenzhen Component Index closed at 13404.06, up 0.19% [1] Stock Performance - Notable gainers in the personal care sector included: - Yanjing Co., Ltd. with a closing price of 9.07, up 4.25% [1] - Liangmian Needle with a closing price of 6.38, up 2.90% [1] - Jieya Co., Ltd. with a closing price of 32.98, up 2.42% [1] - Conversely, Yiyi Co., Ltd. saw a significant decline, closing at 29.34, down 4.37% [2] - Other notable decliners included: - Zhenjian Medical with a closing price of 40.91, down 0.94% [2] - Beijia Clean with a closing price of 30.80, down 0.61% [2] Capital Flow Analysis - The personal care products sector saw a net outflow of 47.21 million yuan from institutional investors, while retail investors contributed a net inflow of 24.22 million yuan [2] - The capital flow for specific stocks showed: - Yanjing Co., Ltd. had a net inflow of 8.22 million yuan from institutional investors [3] - Liangmian Needle experienced a net inflow of 2.80 million yuan from retail investors [3] - Zhenjian Medical faced a net outflow of 8.66 million yuan from institutional investors [3]
零售行业2026年度投资策略:从保值到颜值,再到情绪价值
KAIYUAN SECURITIES· 2025-11-02 12:13
Industry Overview - In 2025, social consumption and retail enterprises are slowly recovering, with segments like gold jewelry benefiting from high gold prices, while cosmetics and medical aesthetics face intense competition and the rise of domestic brands. Notably, "emotional consumption" remains a key indicator of market vitality [2][8]. Segment Analysis Gold Jewelry - The industry has undergone significant changes, with high gold prices and declining wedding demand affecting traditional brand competitiveness. The rise of emotional consumption and social media marketing has led to the emergence of new brands with differentiated products and consumer insights. Opportunities are seen in high-end Chinese gold and trendy gold segments [3][25]. Retail E-commerce - Offline retailers are transforming from selling "goods" to offering "services and experiences," leveraging their advantages to attract traffic back. Online cross-border e-commerce is expected to enter a demand improvement phase with the easing of interest rates, further enhanced by AI integration [3][19]. Cosmetics - Domestic brands are capitalizing on cultural roots and emotional value to increase market share. Innovations in product safety and emotional value are key, with opportunities in regional and technological narratives, sensitive skin anti-aging, and domestic color cosmetics [3][85]. Medical Aesthetics - High-end consumers show resilience, with a focus on differentiated products from upstream manufacturers and mergers and acquisitions among downstream medical institutions to drive growth [3][5]. Investment Recommendations - Gold Jewelry: Favor brands with differentiated product strength and consumer insights, recommending Chao Hong Ji, Lao Pu Gold, and Chow Tai Fook, with beneficiaries including Chow Sang Sang [3][52]. - Retail E-commerce: Support offline retailers adapting to trends and AI-enabled cross-border e-commerce leaders, recommending Yonghui Supermarket, Ai Ying Shi, Ji Hong Co., and Sai Wei Times [3][82]. - Cosmetics: Highlight domestic brands that meet emotional value and safety innovation, recommending Mao Ge Ping, Pechoin, Shangmei Co., Juzi Biological, Wanmei Biological, and Runben Co. [3][52]. - Medical Aesthetics: Focus on differentiated medical aesthetic product manufacturers and expanding chain medical institutions, recommending Ai Mei Ke and Ke Di-B, with beneficiaries including Mei Li Tian Yuan Medical Health [3][52].
润本股份(603193) - 关于使用部分暂时闲置募集资金进行现金管理到期赎回的公告
2025-10-31 09:49
证券代码:603193 证券简称:润本股份 公告编号:2025-046 润本生物技术股份有限公司 关于使用部分暂时闲置募集资金进行现金管理 到期赎回的公告 截至本公告披露日,公司本次使用募集资金进行现金管理的情况如下: 1 | | 中国银行股 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 2 | 份有限公司 | 结构 | 结构 | 13,200,000.00 | 3.09% | 202,263.78 | 2024/11/ | 2025/5/ | | | 广州珠江支 | 存款 | 存款 | | | | 12 | 12 | | | 行 | | | | | | | | | | 中国银行股 | | | | | | | | | 3 | 份有限公司 | 结构 | 结构 | 163,200,000.00 | 1.05% | 859,147.40 | 2024/11/ | 2025/5/ | | | 广州珠江支 | 存款 | 存款 | | | | 12 | 14 | | | 行 | | | | | | | | | | 中国银 ...
个护用品板块10月31日涨1.02%,稳健医疗领涨,主力资金净流出4569.07万元
Market Overview - The personal care products sector increased by 1.02% on October 31, with稳健医疗 leading the gains [1] - The Shanghai Composite Index closed at 3954.79, down 0.81%, while the Shenzhen Component Index closed at 13378.21, down 1.14% [1] Stock Performance - Key stocks in the personal care products sector showed varied performance, with the following notable changes: - 稳健医疗 (300888) closed at 41.30, up 2.00% with a trading volume of 100,200 shares and a turnover of 413 million yuan [1] - 洁雅股份 (301108) closed at 32.20, up 1.61% with a trading volume of 28,700 shares [1] - 豪悦护理 (6005009) closed at 32.60, up 1.46% with a trading volume of 16,900 shares [1] - 百亚股份 (003006) closed at 23.33, down 0.30% with a trading volume of 28,400 shares [1] Capital Flow - The personal care products sector experienced a net outflow of 45.69 million yuan from institutional investors, while retail investors saw a net inflow of 48.90 million yuan [2] - The following stocks had significant capital flow: - 稳健医疗 had a net inflow of 19.47 million yuan from institutional investors, but a net outflow from retail investors [3] - 登康口腔 saw a net inflow of 41.71 million yuan from speculative funds [3] - 豪悦护理 experienced a net outflow of 8.07 million yuan from institutional investors [3]